Literature DB >> 11590545

Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

K E Heath1, A Campos-Barros, A Toren, G Rozenfeld-Granot, L E Carlsson, J Savige, J C Denison, M C Gregory, J G White, D F Barker, A Greinacher, C J Epstein, M J Glucksman, J A Martignetti.   

Abstract

May-Hegglin anomaly (MHA) and Fechtner (FTNS) and Sebastian (SBS) syndromes are autosomal dominant platelet disorders that share macrothrombocytopenia and characteristic leukocyte inclusions. FTNS has the additional clinical features of nephritis, deafness, and cataracts. Previously, mutations in the nonmuscle myosin heavy chain 9 gene (MYH9), which encodes nonmuscle myosin heavy chain IIA (MYHIIA), were identified in all three disorders. The spectrum of mutations and the genotype-phenotype and structure-function relationships in a large cohort of affected individuals (n=27) has now been examined. Moreover, it is demonstrated that MYH9 mutations also result in two other FTNS-like macrothrombocytopenia syndromes: Epstein syndrome (EPS) and Alport syndrome with macrothrombocytopenia (APSM). In all five disorders, MYH9 mutations were identified in 20/27 (74%) affected individuals. Four mutations, R702C, D1424N, E1841K, and R1933X, were most frequent. R702C and R702H mutations were only associated with FTNS, EPS, or APSM, thus defining a region of MYHIIA critical in the combined pathogenesis of macrothrombocytopenia, nephritis, and deafness. The E1841K, D1424N, and R1933X coiled-coil domain mutations were common to both MHA and FTNS. Haplotype analysis using three novel microsatellite markers revealed that three E1841K carriers--one with MHA and two with FTNS--shared a common haplotype around the MYH9 gene, suggesting a common ancestor. The two new globular-head mutations, K371N and R702H, as well as the recently identified MYH9 mutation, R705H, which results in DFNA17, were modeled on the basis of X-ray crystallographic data. Altogether, our data suggest that MHA, SBS, FTNS, EPS, and APSM comprise a phenotypic spectrum of disorders, all caused by MYH9 mutations. On the basis of our genetic analyses, the name "MYHIIA syndrome" is proposed to encompass all of these disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590545      PMCID: PMC1274350          DOI: 10.1086/324267

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

1.  End-stage renal disease in two pediatric patients with Fechtner syndrome.

Authors:  M M Moxey-Mims; G Young; A Silverman; D M Selby; J G White; K K Kher
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

2.  The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.

Authors:  J A Martignetti; K E Heath; J Harris; N Bizzaro; A Savoia; C L Balduini; R J Desnick
Journal:  Am J Hum Genet       Date:  2000-03-17       Impact factor: 11.025

3.  Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2.

Authors:  Y S Choy; S L Dabora; F Hall; V Ramesh; Y Niida; D Franz; J Kasprzyk-Obara; M P Reeve; D J Kwiatkowski
Journal:  Ann Hum Genet       Date:  1999-09       Impact factor: 1.670

4.  A simple, efficient method for the separate isolation of RNA and DNA from the same cells.

Authors:  N C Nicolaides; C J Stoeckert
Journal:  Biotechniques       Date:  1990-02       Impact factor: 1.993

5.  Mutations in the myosin VIIA gene cause non-syndromic recessive deafness.

Authors:  X Z Liu; J Walsh; P Mburu; J Kendrick-Jones; M J Cope; K P Steel; S D Brown
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

6.  Glutamic acid-88 is close to SH-1 in the tertiary structure of myosin subfragment 1.

Authors:  R C Lu; A Wong
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

7.  Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexes.

Authors:  P Nurden; A Nurden
Journal:  C R Acad Sci III       Date:  1996-08

8.  Defective myosin VIIA gene responsible for Usher syndrome type 1B.

Authors:  D Weil; S Blanchard; J Kaplan; P Guilford; F Gibson; J Walsh; P Mburu; A Varela; J Levilliers; M D Weston
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

9.  Platelet count and platelet size in males and females.

Authors:  B J Bain
Journal:  Scand J Haematol       Date:  1985-07

10.  The mouse Snell's waltzer deafness gene encodes an unconventional myosin required for structural integrity of inner ear hair cells.

Authors:  K B Avraham; T Hasson; K P Steel; D M Kingsley; L B Russell; M S Mooseker; N G Copeland; N A Jenkins
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  76 in total

1.  Genotype-phenotype correlation in X-linked Alport syndrome.

Authors:  Mir Reza Bekheirnia; Berenice Reed; Martin C Gregory; Kim McFann; Alireza Abdollah Shamshirsaz; Amirali Masoumi; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

Review 2.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

3.  Coiled-coil nanomechanics and uncoiling and unfolding of the superhelix and alpha-helices of myosin.

Authors:  Douglas D Root; Vamsi K Yadavalli; Jeffrey G Forbes; Kuan Wang
Journal:  Biophys J       Date:  2006-01-26       Impact factor: 4.033

4.  An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.

Authors:  James M Holaska; Katherine L Wilson
Journal:  Biochemistry       Date:  2007-07-10       Impact factor: 3.162

5.  Myosin II regulates extension, growth and patterning in the mammalian cochlear duct.

Authors:  Norio Yamamoto; Takayuki Okano; Xuefei Ma; Robert S Adelstein; Matthew W Kelley
Journal:  Development       Date:  2009-05-13       Impact factor: 6.868

Review 6.  The heavy chain has its day: regulation of myosin-II assembly.

Authors:  Natalya G Dulyaninova; Anne R Bresnick
Journal:  Bioarchitecture       Date:  2013 Jul-Aug

7.  GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome.

Authors:  Tobias Hermle; Ronen Schneider; David Schapiro; Daniela A Braun; Amelie T van der Ven; Jillian K Warejko; Ankana Daga; Eugen Widmeier; Makiko Nakayama; Tilman Jobst-Schwan; Amar J Majmundar; Shazia Ashraf; Jia Rao; Laura S Finn; Velibor Tasic; Joel D Hernandez; Arvind Bagga; Sawsan M Jalalah; Sherif El Desoky; Jameela A Kari; Kristen M Laricchia; Monkol Lek; Heidi L Rehm; Daniel G MacArthur; Shrikant Mane; Richard P Lifton; Shirlee Shril; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

8.  Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.

Authors:  Nadege Bondurand; Florence Dastot-Le Moal; Laure Stanchina; Nathalie Collot; Viviane Baral; Sandrine Marlin; Tania Attie-Bitach; Irina Giurgea; Laurent Skopinski; William Reardon; Annick Toutain; Pierre Sarda; Anis Echaieb; Marilyn Lackmy-Port-Lis; Renaud Touraine; Jeanne Amiel; Michel Goossens; Veronique Pingault
Journal:  Am J Hum Genet       Date:  2007-10-22       Impact factor: 11.025

9.  Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.

Authors:  Oonagh Dowling; Analisa Difeo; Maria C Ramirez; Turgut Tukel; Goutham Narla; Luisa Bonafe; Hulya Kayserili; Memnune Yuksel-Apak; Amy S Paller; Karen Norton; Ahmad S Teebi; Valerie Grum-Tokars; Gail S Martin; George E Davis; Marc J Glucksman; John A Martignetti
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

Review 10.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.